Course Code: REL-ALL-0-CSDDSPM
Hours: 3.75
Type: Online Course
Content Expiration Date: 12/31/2024
Learning Objectives:
Define drug diversion and identify various classifications of medications that are diverted or abused.
Recognize rationales for prescription drug diversion.
Recognize and prevent drug diversion behaviors and activities.
Identify tools to detect and deter drug diversion.
Define key terms necessary to understand SUD.
Name common controlled and noncontrolled medications that are abused.
Describe screening and assessment tools helpful in identifying SUD.
Describe the nonpharmacological and pharmacological treatments of SUD.
Define specific types of pain.
Identify options for pain management using the most recent CDC guidelines.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Drug Classifications and Diversion
Defining Drug Diversion
Classifications
State-Level Classifications
Further Categorization
Legal Ramifications
Review
Summary
Section 3: Rationales and Behaviors
Rationales for Diversion
Income-Driven Diversion
Substance Use and Self-Medication
Common Diversion Methods to Obtain Prescription Medications
Common Drug Diversion Behaviors in Clinical Practice
Individual Patient Behaviors
Prescriber and Support Staff Behaviors
Meet JT
A Pill Mill
An Oxycodone Addiction
The Small-Town Pharmacist
Sharing Medications
Review
Summary
Section 4: Detection and Prevention
Patient Histories and Physical Assessment
Prescription Drug Monitoring Programs (PDMPs)
Patient-Prescriber Agreements or “Narcotics Contracts”
Drug Screens
Prevention of Diversion and Abuse Checklist
Pharmacist Refusal to Fill Prescriptions
Patient Counseling and Drug Regimen Review
Diagnosis Verification
Reporting Diversion
Review
Summary
Section 5: Substance Use Disorders
Scope of the Problem
Definitions
Review
Summary
Section 6: The Reward Pathway of the Brain
Anatomy and Physiology
Factors Contributing to Addiction
Review
Summary
Section 7: Signs, Symptoms, and Substances Used
Signs and Symptoms
Illicit, Prescription, and OTC Substances
Review
Summary
Section 8: Screening and Treatment of SUD
Screening
Nonpharmacological Treatment of SUD
Detoxification
Pharmacological Treatment of SUD
Naloxone Treatment of Opioid Overdose
Review
Summary
Section 9: Defining and Managing Pain
Pain
Neuropathic Pain
Nociceptive Pain
Acute vs. Chronic Pain
Pain Management
Trends in Pain Management
Prescribing Rates and Drug Overdose
Review
Summary
Section 10: Assessment and Establishing Goals of Treatment
Assessment
Pain Scores
Activities of Daily Living
Psychiatric Assessment
Expectations of Pain Management
Review
Summary
Section 11: Treatment of Pain
Nonpharmacological Treatment
Pharmacological Management of Nociceptive Pain
Chronic Neuropathic Pain
Adjuvant Drug Therapy
Opioid-Related Pain Management Recommendations
Review
Summary
Section 12: Pain Management in Patients with SUD
Treatment of Pain
Acute Pain Treatment in SUD
Chronic Pain Management in SUD
Review
Summary
Section 13: Conclusion
Course Summary
Course Contributors
Resources
References
Instructor: Doug Raiff, PharmD, BCPS
Doug earned his Doctor of Pharmacy (PharmD) from the Raabe College of Pharmacy at Ohio Northern University in 2011. He completed a PGY-1 residency in Pharmacy Practice at MetroHealth Medical Center in Cleveland, Ohio, and completed a specialty residency in Drug Information and Medical Information at Duke University Hospital and GlaxoSmithKline. He is a board-certified pharmacotherapy specialist, and has worked as a clinical pharmacist within the Center for Medication Policy of the Duke University Health System since 2013. His primary responsibilities include chairing the Pharmaceutical Utilization Management Program and Medication Alert Optimization Committee for the health system. He also serves as an APPE preceptor, PGY-1 residency coordinator, and is a member of the Duke University Health System Institutional Review Board.
Instructor: Johnny J. Bethea, II, RPh
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council.
Target Audience:
The target audience for this course is: Nurses; Pharmacists; Physician Assistants; Physicians; in the following settings: All Healthcare Settings.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.